Drugs Influencing the Airways Flashcards

1
Q

what is Poiseuille’s Law?
what does it explain?

A

Poiseuille’s Law: describes the relationship between airflow, pressure gradient (Barometric pressure vs alveolar pressure) and resistance to airflow (combination of length of airways and radius of airways + viscosity of gas)
Pressure (P) = flow (V.) x resistance (R)
Flow = pressure / resistance
This equation suggests most resistance would be in smallest airways
BUT actually, highest resistance is in large airways (trachea > medium bronchi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why is there higher resistance in the large airways?

A

This is due to the bifurcating nature of airways
Despite the radius of individual respiratory bronchioles being small there are a huge number of them → total cross-sectional area of them is much greater than the cross sectional area of the trachea
Diameter of trachea very large, but cross-sectional area is relatively small

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

where does majority of airway resistance reside?

A

Majority (80%) of airways resistance resides in upper airways: pharynx, larynx and airways with diameter >2 mm
Smaller airways <2 mm contribute about 20% of airway resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does this graph show?

A

This graph shows the increases in total cross-sectional area the airway generation number increases.
This graph also shows that there is an inverse relationship between velocity of air and total cross-sectional area.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is physiological control of airway diameter achieved?

A

Airways contain smooth muscle - allows radius of airway to be controlled physiologically
Contraction of smooth muscles –> bronchoconstriction
Relaxation of smooth muscles –> bronchodilation
The smooth muscle in the airway controlled by the ANS and also influenced by several other mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the different mechanisms that smooth muscle in the airway are controlled by?

A

Parasympathetic innervation
No sympathetic innervation
NANC innervation
Mast cells
Mechanical receptors
CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does parasympathetic innervation of the smooth muscle of bronchi result in?

A

Parasympathetic innervation
Efferent parasympathetic preganglionic fibres run in vagus nerve to ganglia found in walls of airways
They stimulate ACh release from postganglionic fibres - stimulates muscarinic M3 receptors on smooth muscle
This causes contraction of smooth muscle → bronchoconstriction
There is 30% vagal tone to airways at rest
Muscarinic antagonist (atropine) will reduce airways resistance by 30% by antagonising this parasympathetic pathway
Occurs in healthy individual → system influences airway diameter at rest
Cigarette smoke will stimulate this system –> bronchoconstriction
This therefore increases airway resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what parts of the smooth muscle do not have sympathetic innervation?

A

However, β2-adrenoreceptors are found on airway smooth muscle
These are stimulated by circulating adrenaline (released by adrenal medulla)
Binding of adrenaline to this receptor results in smooth muscle relaxation –> bronchodilation
β2-receptor stimulation also inhibits the activity of mast cells found in the area
These mast cells usually release bronchoconstrictors –> Spasmogens e.g. histamine, platelet activating factor, leukotrienes.
β2-receptor stimulation also promotes muco-ciliary escalator activity in the airways
This is an important defensive mechanism for moving foreign particles up out of airways
β2-receptor agonists can therefore be a target for asthma treatment (see later)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is NANC innervation and what does it innervate?

A

Non-adrenergic non-cholinergic arm of the ANS
Stimulation of this system results in relaxation of smooth muscle –> bronchodilation (decreases airway resistance)
Transmitters involved: VIP + NO
Another transmitter, substance P → causes bronchoconstriction
may have a role in precipitation of asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does stimulation of mast cells do?

A

Mast cells are present in high numbers in the airway walls
They are stimulated by allergens
Stimulation of mast cells result in degranulation
This is where Spasmogens are released from their contents e.g. histamine, platelet activating factor, leukotrienes
They cause bronchoconstriction
They contribute to pathology of asthma
Mast cells also release Chemotaxins which attract eosinophils and neutrophils which release further Spasmogens which have further effect leading to the longer term effects of asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what different mechanical receptors do airways contain?

A

Airways contain several different types of mechanical receptors:
Stimulation of rapidly adapting receptors (RAR) by foreign bodies or chemical irritants initiates a reflex with afferent and efferent arms in the vagus
These result in contraction of smooth muscle –> bronchoconstriction
Stimulation of slowly adapting pulmonary stretch receptors (PSR) by stretch (e.g. large breath) –> bronchodilation
Found between smooth muscle of trachea and lower airway
Afferent fibres from these PSR are also found in vagus nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does CO2 act on airway smooth muscle?

A

CO2 Acts directly on airway smooth muscle –> relaxation –> bronchodilation
This is an important mechanism to ensure good ventilation in all parts of lung:
They are important in matching ventilation to perfusion
CO2 will build up in under-ventilated areas of lung → bronchodilation - improves ventilation to these areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the difference in airway resistance at residual volume and TLC?
what are the 2 reasons for this?

A

At residual volume, airway resistance is very high
At TCL air way resistance is very low
Airway resistance decreases steeply as lung volume increases from RV to TLC

2 reasons for this:
Radial traction
Alveolar interdependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is radial traction?

A

In the lungs the airways are embedded in lung parenchyma (connective tissue)
Parenchyma acts as a splint to hold airways open
During inspiration, lung inflation stretches parenchyma fibres
This causes an increase in radial traction which causes an increase in the diameter of airways, therefore there is a decrease in airway resistance
At rest, this is what stops airway resistance increasing too much at FRC (FRC somewhere between RV and TLC) keeps it low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Alveolar interdependence?

A

Alveolar interdependence: Neighbouring alveoli share walls –> adjacent alveoli will help keep each other open
Mechanical tethering of the alveoli with the small conducting airways keeps smallest conducting airways (with thicker walls than alveoli) open
During inspiration, each alveolus inflates itself - this pulls on conducting airways keeping them open. It also helps keep other alveoli open as well.
This helps lower airway resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does COPD affect airway resistance compared to someone w/o it?

A

Effect of lung volume on airway resistance during normal tidal breathing (from FRC) is very little as lung volume does not increase very much so airway resistance does not change much (moving up and down red line a little bit)
COPD causes a breakdown of the alveoli walls which causes a loss of radial traction and mechanical tethering which help to keep airways open. This causes increase airways resistance

17
Q

explain pharmacological control of airway diameter in asthma: bronchodilators

A

Asthma: episodes of bronchoconstriction –> airway diameter decreases –> airway resistance increasing which therefore makes it difficult to breathe
People suffering from asthma have bronchial hyperactivity due to inflammation of airway mucosa –> the mucosa will be infiltrated by inflammatory cells and thickened
Therefore during exacerbations (asthma attack):
Inflammatory cells release mediators (Spasmogens) –> contraction of bronchial smooth muscle –> bronchoconstriction –> increase in airway resistance
Spasmogens also cause an increase in airway secretions which cause narrowing of the lumen causing further increased air way resistance.

18
Q

what does the pharmacological treatment of asthma target?

A

Target either:
Bronchoconstrictor component of disease
Or Inflammatory/immune component

19
Q

what does stimulation of β2-receptors on airway smooth muscle do?

A

Stimulation of β2-receptors on airway smooth muscle –> bronchodilation
The most prescribed anti-asthma drug are β2-agonists
Agonists (A or NA) binding stimulates these GPCRs via AC/cAMP/PKA pathway:
Ligand binding activates adenylyl cyclase, ↑ [cAMP] inside cell → activates protein kinase A → phosphorylation of proteins controlling intracellular Ca2+ concentration → decrease Ca2+ inside cells allows smooth muscle to relax
β2-receptors also found on inflammatory/immune cells
Therefore, agonists also decrease inflammation by inhibiting action of these cells

20
Q

what is the most prescribed β2-agonist?

A

Most prescribed β2-agonist is Salbutamol:
Inhaled using inhaler
short-acting;
Side effects include: tachycardia, tremor and most seriously airway hyper-responsiveness (due to increase in airway sensitivity to noxious stimuli which can lead to tolerance to drug)

21
Q

name other β2-agonists and their function

A

Other β2-agonists are Salmeterol/Terbutaline:
slower onset
long-acting –> not for help with relief of acute asthma attack
Terbutaline is only one safe during pregnancy

22
Q

what are methylxanthines?
mechanism of action?
examples?

A

Methylxanthines (another group of bronchodilators)
Oral administration
They are PDE (phosphodiesterase) inhibitors
↑ cAMP by inhibiting phosphodiesterase (PDE) →SM relaxation –> bronchodilation
↑ [cAMP] inside cell → activates protein kinase A → phosphorylation of proteins controlling intracellular Ca2+ concentration → ↓ Ca2+ inside cells allows smooth muscle to relax
Also reduce inflammation by inhibiting action of immune/inflammatory cells
Example: Theophylline/aminophylline:
Oral administration
Narrow therapeutic window - doses above this cause serious side effects including headache, restlessness, abdominal symptoms, arrhythmias
therefore clinical use has decreased for use in asthma

23
Q

what do anti-cholinergic/muscarinic antagonists do?

A

They block the bronchoconstriction action of ACh (released from postganglionic parasympathetic nerve fibres)
Ipratropium (analogue of atropine):
Inhaled
By using inhalation as a route of administration we can target the specific muscarinic receptors at the right organs.
It is quaternary nitrogen in structure which prevents systemic absorption and therefore decreases systemic side effects than if we were to use atropine (e.g. dry mouth, cough on administration, altered taste).
Ipratropium also used in COPD patients combined with salbutamol

24
Q

what does pharmacological treatment of airway inflammation in asthma target?

A

People who have asthma have inflammation in their airways
Pharmacological treatment of inflammation in airways will target the inflammatory processes and immune cells which contribute to inflammation of airways.

25
Q

what are the 5 different mechanisms/drugs that control of airway inflammation in asthma?

A
  1. Corticosteroids
  2. Targeting the leukotriene pathway
  3. Sodium cromoglicate/cromolyn
  4. Histamine receptor antagonists
  5. Monoclonal anti-IgE antibodies
26
Q

how do corticosteroids control of airway inflammation in asthma?
give examples

A

They cause a decrease in airway inflammation and hyper-responsiveness
They supress genes that are activated in inflammatory diseases
This therefore increases lung function and reduces number and severity of asthma attacks.
Corticosteroid prevents rather than relieves asthma
Not used for treatment of acute asthma attack.
Administration is via inhalation as it deliver drug straight to lung to reduce systemic side effects.
Example: Beclomethasone:
Inhaled –> straight to lungs
It is metabolised to its active form in the lungs which also helps reduce systemic side-effects

27
Q

how does targeting the leukotriene pathway control of airway inflammation in asthma?
give examples

A

Leukotrienes are released from mast cells in asthma –> bronchoconstriction and increased mucus secretion and can stimulate eosinophil and neutrophils (long term effects of asthma
Inhibition of the action of leukotrienes is a target for treatment of asthma.
Two classes of drugs that that have been developed
Leukotriene formation antagonists → Zileuton:
Oral
They block production of leukotriene by inhibiting enzyme responsible for leukotriene production, 5-lipooxygenase;
They are not widely used as short half-life therefore need to be taken multiple times a day (problem with compliance)
Leukotriene receptor antagonist → Montelukast:
oral
single daily dose (better compliance)
used in severe chronic and exercise-induced asthma (where there are high levels of leukotrienes)
Cause bronchodilation; decrease mucus secretion and decreased inflammation

28
Q

how do sodium cromoglicate/cromolyn control of airway inflammation in asthma?
give examples

A

Inhaled
Prophylactic (preventative) treatment for asthma
Mechanism of action not fully understood
Anti-inflammatory effect: inhibits release of inflammatory mediators from mast cells and inhibits RAR axon reflexes
Takes 4-weeks to be effective –> can be so effective may decrease need for corticosteroid treatment or bronchodilators
Mild side effects: coughing, wheezing, dry throat

29
Q

how do histamine receptor antagonists control of airway inflammation in asthma?
give examples

A

Histamine released from mast cells in degranulation
Ketotifen:
Oral
H1-receptor antagonist
Anti-inflammatory effects seen after 6-12 weeks treatment
They reduce reliance on corticosteroids and bronchodilators
Few side effects e.g. include drowsiness (10-15% patients)

30
Q

how do monoclonal anti-IgE antibodies control of airway inflammation in asthma?
give examples

A

IgE is produced by B cells when sensitised by allergens
Binding of IgE to mast cells –> degranulation of mast cells –> releasing inflammatory mediators (e.g. Spasmogens) which cause inflammation and bronchoconstriction
Example: Omalizumab:
Administration via s.c. injection every 2-4 weeks
They decrease circulating IgE therefore decrease mast cell degranulation and inflammation
Used in severe allergic asthma (in whom high doses of corticosteroids + β2-agonists are not controlling symptoms)
Use is restricted to hospital as in rare instances can cause anaphylaxis

31
Q

what is the prevalence and symptoms of aspirin-induced asthma?

A

Prevalence:
~21% of patients, but possibly underreported
Women > men
Sensitivity often develops in adulthood
Symptoms: rhinorrhoea (running nose), nasal congestion, sinusitis
Difference between patients who get aspirin induce asthma is the Upregulated 5-lipoxygenase (enzyme for leukotriene production) therefore increased leukotrienes
Montelukast used as a treatment as well as standard treatments already prescribed.